91ÖÆƬ³§

The global market for Iohexol Injection was valued at US$ 1259 million in the year 2023 and is projected to reach a revised size of US$ 1813 million by 2030, growing at a CAGR of 5.1% during the forecast period.
Iohexol injection is a non-ionic, water-soluble contrast agent used in diagnostic imaging procedures such as computed tomography (CT) scans and angiography to enhance the visibility of blood vessels, tissues, and organs by highlighting their structures and abnormalities for accurate diagnosis and treatment planning.
Market Drivers:
Diagnostic Precision: Iohexol injection aids in improving diagnostic accuracy by providing enhanced contrast in imaging studies, enabling healthcare professionals to visualize internal body structures with greater clarity and detail for accurate interpretation.
Safety Profile: As a non-ionic contrast agent, iohexol is associated with lower risk of adverse reactions compared to ionic contrast media, making it a preferred choice for patients with a history of sensitivity to contrast agents and reducing the incidence of allergic responses during imaging procedures.
Renal Safety: Iohexol has a lower risk of causing contrast-induced nephropathy (CIN) compared to some other contrast agents, making it a safer option for patients with compromised renal function or those at higher risk of kidney injury following contrast-enhanced imaging studies.
Technological Advancements: Ongoing research and development efforts focus on enhancing the formulation of iohexol injection, improving patient tolerability, reducing osmolality, and optimizing imaging protocols to deliver high-quality diagnostic images while ensuring patient safety.
Clinical Applications: The versatility of iohexol injection in various imaging modalities, including CT scans, angiography, and other radiological procedures, drives its widespread use in diagnostic imaging across medical specialties such as radiology, interventional cardiology, and vascular surgery.
Market Challenges:
Competitive Landscape: The contrast media market is competitive, with multiple manufacturers offering a range of contrast agents, including iohexol, leading to pricing pressures, market saturation, and challenges in differentiating products based on efficacy, safety, and cost-effectiveness.
Regulatory Compliance: Compliance with stringent regulatory requirements, quality standards, and safety guidelines for contrast media production, labeling, and distribution poses challenges for manufacturers in ensuring product quality, consistency, and regulatory approval for market authorization.
Cost Constraints: The cost of contrast media, imaging procedures, and healthcare services can be a barrier for some healthcare facilities, patients, and healthcare systems, impacting the accessibility and affordability of contrast-enhanced imaging studies utilizing iohexol injection.
Patient Factors: Variability in patient factors such as allergies, renal function, comorbidities, and medication history can influence the choice of contrast agents, dosing considerations, and risk assessment for iohexol injection, requiring individualized patient care and monitoring.
Adverse Events Management: Despite its favorable safety profile, iohexol injection can still lead to adverse reactions such as hypersensitivity reactions, nephrotoxicity, and rare but serious side effects, necessitating prompt recognition, management, and mitigation of adverse events during and after imaging procedures.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Iohexol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol Injection.
The Iohexol Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Iohexol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iohexol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GE Healthcare
YRPG
BeiLu Pharma
Imax
Segment by Type
350mg I/ml
240mg I/ml
300mg I/ml
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iohexol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Iohexol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.